{
    "Trade/Device Name(s)": [
        "TRILOGY Analyzer"
    ],
    "Submitter Information": "Drew Scientific, Inc.",
    "510(k) Number": "K070704",
    "Predicate Device Reference 510(k) Number(s)": [
        "K851172",
        "K000926",
        "K011900",
        "K003247",
        "K011596"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "CGX",
        "CDQ",
        "CGZ",
        "CEM",
        "JGS",
        "JJE"
    ],
    "Summary Letter Date": "June 19, 2007",
    "Summary Letter Received Date": "June 20, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose",
        "Creatinine",
        "Urea nitrogen",
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "TRILOGY Analyzer",
        "Optional Ion Selective Electrode (ISE) module"
    ],
    "Method(s)/Technology(ies)": [
        "Spectrophotometric",
        "Potentiometric",
        "Ion selective electrode (ISE)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "System",
        "Platform"
    ],
    "Document Summary": "FDA 510(k) summary for TRILOGY Analyzer, an automated clinical chemistry analyzer with optional ISE module for measurement of analytes in serum and urine.",
    "Indications for Use Summary": "For in vitro quantitative determination of glucose, creatinine, and urea nitrogen in serum, and sodium, potassium, and chloride in serum and urine to aid diagnosis and treatment of metabolic and electrolyte disorders.",
    "fda_folder": "Clinical Chemistry"
}